Monitoring the progression of Alzheimer's disease with latent transition models

dc.contributor.authorGu, Jiena
dc.date.accessioned2016-08-15T14:27:01Z
dc.date.available2016-08-15T14:27:01Z
dc.date.graduationmonthAugust
dc.date.issued2016-08-01
dc.description.abstractBACKGROUND AND PURPOSE: Alzheimer's disease is currently a neurodegenerative diseases without any effective treatments to slow or reverse the progression. To develop any potential treatments, the need of a good statistical model to assess the progression of Alzheimer's disease is becoming increasingly urgent. This study proposed a latent transition model to monitor the progression of Alzheimer's disease which can help the development of a given proposed treatment. METHOD: A latent transition model was used to assess the progression of Alzheimer's disease. The volume of Hippocampus and fluorodeoxyglucose-PET (FDG) were employed as biomarkers in this model. These two biomarkers are very sensitive to the pathological signs of the Alzheimer's disease. The proposed latent transition model was performed with real data from Alzheimer's Disease Neuroimaging Initiative (ADNI), which contain 2,126 participants from 2005 to 2014. RESULTS/FINDINGS: The latent transition model suggested six states of disease progression and two different pathological profiles. One progression profile was mainly determined by the biomarker of FDG and the other by the volume of Hippocampus. CONCLUSION: The results revealed the existence of various progression profiles of Alzheimer's disease, suggesting a new way to evaluate the disease progression.
dc.description.advisorWei-Wen Hsu
dc.description.degreeMaster of Science
dc.description.departmentDepartment of Statistics
dc.description.levelMasters
dc.identifier.urihttp://hdl.handle.net/2097/32919
dc.language.isoen_US
dc.publisherKansas State University
dc.rights© the author. This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.subjectLatent Transition Models
dc.subjectDisease ProgressionAlzheimer's Disease
dc.titleMonitoring the progression of Alzheimer's disease with latent transition models
dc.typeReport

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
JienaGu2016.pdf
Size:
744.72 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.62 KB
Format:
Item-specific license agreed upon to submission
Description: